In the last trading session, 0.17 million shares of the ABVC BioPharma Inc (NASDAQ:ABVC) were traded, and its beta was 0.11. Most recently the company’s share price was $1.15, and it changed around -$0.06 or -4.96% from the last close, which brings the market valuation of the company to $19.29M. ABVC currently trades at a discount to its 52-week high of $1.79, offering almost -55.65% off that amount. The share price’s 52-week low was $0.40, which indicates that the current value has risen by an impressive 65.22% since then.
ABVC BioPharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ABVC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. ABVC BioPharma Inc is expected to report earnings per share of 0 for the current quarter.
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Instantly ABVC has showed a red trend with a performance of -4.96% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.5200 on recent trading dayincreased the stock’s daily price by 24.34%. The company’s shares are currently up 94.92% year-to-date, but still down -22.30% over the last five days. On the other hand, ABVC BioPharma Inc (NASDAQ:ABVC) is 26.23% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.39%.
ABVC Dividends
ABVC BioPharma Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 59.67 shares worth $68617.0, making up 0.36% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 46.95 shares worth around $53989.0, which represents about 0.28% of the total shares outstanding.
